Pain Therapeutics, Inc. (PTIE)

S&P 500: 1,242.31
Change: 0.44%

A biopharmaceutical company that develops novel drugs for pain management and oncology.

Recs

Avatar onontrading (< 20) Submitted: 4/23/08 11:33 PM : Start Price: $7.01 PTIE Score: 36.89

This stock has an average seasonality of 13% over the mid summer

Featured Broker Partners